Regenerative Medicine Market, By Type (Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engi

Published Date: January 2020 | Report Code : HC2044444


The Global Regenerative Medicine Market size was valued at USD 11.6 million in 2018 and is anticipated to grow at a CAGR of 21.2% during the forecast period. Regenerative medicine is a subdivision of medicine that focuses on the development of therapies that can replace or regenerate diseased, injured or defective cells, organs, or tissue to establish or restore function and structure. The regenerative medicine helps scientists and researchers to grow organs and tissues in the research institutes and laboratory and safely implant them when the body is unable to heal itself.   

Government support in regenerative medicine research, rising geriatric population and the resulting increase in chronic disease prevalence, and an increase in a number of regenerative medicine products are factors that will propel the global regenerative medicine market during the forecast period. Furthermore, high treatment costs, the low purchasing power of consumers, and ethical concerns related to the use of embryonic stem cells in research & development are some of the major constraints on regenerative medicine market growth.

The main function of regenerative medicine is the regeneration or replacement of tissue or organs with healthy organs. Based on type, different types of regenerative medicines such as cell-based immunotherapy & cell therapy products, tissue-engineered products, gene therapy products are used. According to WHO, there are about 18 million cancer cases in 2018, in which 9.5 million cases were in men and 8.5 million in women and an estimated 9.6 million deaths in 2018. Rising demand for organ transplantation and growing government investment for research and development. Therefore, the effect of this factor on the regenerative medicine market is expected to increase soon with continuously evolving technologies.

Key Factors Impacting the Growth of Regenerative Medicine Market:

  • Technological advancements
  • Increasing market demand for population health
  • Government investment in regenerative medicine research
  • Prevalence of Chronic Diseases
  • Digitalization of healthcare systems

The regenerative medicine market segmentation is based on types, applications, and regions.

Type Outlook:

Based on the type, the cell-based immunotherapy & cell therapy segment has covered the largest regenerative medicine market share and is projected to register a higher CAGR during the forecast period. The major factor which drives the growth of this segment is rising demand for cell-based immunotherapies and the establishment of cures act by FDA to streamline the regenerative medicine approval. This expected to enhance the dominance of the cell-based immunotherapy & cell therapy segment in the global market over the forecast period.

Application Outlook:

Based on the application, the market has been segmented into wound care, musculoskeletal disorders, oncology, ocular disorders, diabetes, and other applications. In 2018, the musculoskeletal disorders segment held the highest market share and the segment is also projected to maintain its dominance over the forecast period. This can be due to the rising prevalence of orthopedic diseases along with the rising geriatric population. The geriatric population across the globe and growing incidence of cataract, and rising demand for safe surgery are further expected to raise segment over the forecast period.

Regional Outlook:

Based on the region, the global regenerative medicine market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In terms of revenue, North America holds a dominant position in the global regenerative medicine market. The region's dominance is attributable to favorable government policies for the prevention of disease, rapidly growing geriatric population, increasing funding for regenerative medicine, rising prevalence of chronic diseases, and the presence of well-developed healthcare infrastructure. Highly efficient reimbursement structure and developed healthcare infrastructure in the North America region is one of the key factors driving the consumption of regenerative medicine in this region. Moreover, highly skilled neurosurgeons, a growing number of hospitals and research centers in key countries such as the US and Canada are also propelling the growth of regenerative medicine in the North America region. In Europe, Stringent government regulations regarding hospital devices and rapid industrialization, technological advancement in medicines, growing number of surgeries in countries, such as Germany, the UK, France, Spain, and Italy, are expected to enhance the market growth in the global regenerative medicine market during the forecast. Furthermore, Asia Pacific is estimated to project the fastest growth rate in the global regenerative medicine market during the forecast period. This growth can be accredited to several factors, such as the potentially large patient pool, the rapid development of health infrastructure coupled with increasing healthcare expenditure. In this region, the growing prevalence of chronic diseases, an increase in innovation and development in regenerative medicine, and growing geriatric populations. The growing investment by industry players through the development of new manufacturing units in the region and rising expenditure also contribute to market growth in the Asia Pacific.

The report analyzes factors affecting the regenerative medicine market from both demand and supply side and further analyses market dynamics affecting the market during the forecast year such as driver, restrain, opportunities and future trends. The report also provides comprehensive Porter’s model analysis on the regenerative medicine market for all six regions namely; North America, Western Europe, Eastern Europe, Asia Pacific, Middle East and the Rest of the world.

Competitive Landscape

Innovative advancement in regenerative medicine helps to maintain patient and government support for the development of regenerative medicine. Major companies are investing in research and development. Key market players are also adopting inorganic development strategies like as acquisition of local brands. Similarly, other business models such as joint venture and market entry strategies are helping prominent vendors to make their presence felt in the regenerative medicine market and increase their product portfolio. The key leading players in the market include Vericel, Mimedx Group, Novartis AG, Integra Lifesciences, Stryker Inc., Wright Medical, Spark Therapeutics, Osiris Therapeutics Inc., Kite Pharma, and Organogenesis.

This report also includes the profiles of key regenerative medicine market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.

Key Developments in Regenerative Medicine Market:

  • In August 2018, Novartis AG received approval from the European Commission for luxturna, gene therapy to treat patients with a vision loss. The approval enhances the brand identity of the company and enhances its customer base.
  • In January 2017, Novartis AG signed a partnership agreement with Caribou. The partnership focuses on innovation and the development of regenerative medicine.

Regenerative Medicine MarketRegenerative Medicine Market Timeline (2017-2028)

What Does This Report Provide?

This report provides a detailed understanding of the global regenerative medicine market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Type

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Tissue-Engineered Products
  • Gene Therapy Products

By Application

  • Wound Care
  • Musculoskeletal Disorders
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Type
    • By Application

Reasons to Buy This Report:

  • Market size estimation of the regenerative medicine market on a regional and global basis
  • Unique research Usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy